In breast cancer, p53 has been associated with the modulation of key proteins in mitochondrial metabolism, cytochrome c oxidase 2 synthesis, and the TP53-induced glycolysis and apoptosis regulator (TIGAR) [158]. The gene discussed is TP53; the disease is breast cancer.